Assessment of BTK and BMX inhibition by TL-895 and controls, revealing significant interaction liabilities.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Stromatt et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: